Øg din viden om Ozempic, der ikke kun skaber overskud for investorer, men også bekymringer for synet!
Ozempic har de seneste år skabt bølger som en bestseller blandt vægttabsmedicin, men nu er der kommet nye skræmmende oplysninger frem. Danske sundhedsmyndigheder indkalder EU til at tage fat på to nye studier, der viser en potentiel sammenhæng mellem brugen af Ozempic og sjældne øjensygdomme – en udvikling der kan have alvorlige konsekvenser for troen på denne mirakelpille.
Den danske virksomhed Novo Nordisk, der producerer Ozempic, har set en kæmpe stigning i aktierne, hvilket har tiltrukket sig investorer fra nær og fjern. Men nu bliver deres fokus måske udfordret af de seneste forskningsresultater, som indikerer en forbindelse til synsproblemer, som kan være både skræmmende og skelsættende for de, der allerede bruger medicinen. Er det muligt, at alle de glitterende tal og fremtidsvisioner kan overskygges af alvorlige bivirkninger?
Fra frustrerende venskabsrelationer til potentielle erektionsproblemer; terapi-specialister rapporterer om en bølge af følelsesmæssige implikationer for dem, der bruger Ozempic. Ja, vægttab kan have en dyb indvirkning på ens romantiske liv, og det er vigtigt at huske på, at ikke alt, hvad der glitrer, er guld – især ikke i en vægttabsmedicins verden.
Men vent! Der er en sjov ny trend blandt de rige: mikro-dosering af Ozempic, en kunstnerisk tilgang til vægttab, som gør det muligt for folk at smide de ekstra kilo, mens de holder sig under radaren. Men kan man virkelig stole på disse metoder uden at vide, hvordan det hele påvirker sundheden? Det er et spørgsmål, som flere burde stille sig selv!
With Novo and Lilly expected to maintain their stranglehold on the weight loss drugs market for the foreseeable, many healthcare investors will find that their ...
Study confirms link between Ozempic's active ingredient and low risk of vision loss. Ophthalmology organizations recommend continued use.
Eli Lilly's stock (LLY), up 36% this year, has seen annualized returns of 47% over the last five years. In a note, Barclays analysts led by Emily Field, ...
Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two Danish studies linking Novo ...
The Danish Medicines Agency announced its intention to request a review by the European Committee for the Evaluation of Adverse Reactions (PRAC) concerning ...
The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between Novo Nordisk A/S's blockbuster ...
Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two Danish studies linking Novo ...
The Danish Medicines Agency had been watching reports of a rare eye disease in patients who took Novo's GLP-1 drug but until now have declined to move ...
The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between Novo Nordisk A/S's blockbuster ...
Novo Nordisk's takeover of Catalent and the Danish firm's push to launch a new generation of drugs could boost the importance of GLP agonists in 2025, ...
What to know about reports that some men on weight loss drugs are experiencing erectile dysfunction (ED).
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an ...
A Danish study warns that using Ozempic and Wegovy could double the risk of a condition known to cause vision changes and blindness.
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an ...
LOS ANGELES — In the first head-to-head comparison of two blockbuster drugs used in real-world conditions, people who took Mounjaro lost significantly more ...
Yes, andTovar tells me that it's quite common for weight loss, in general, to impact romantic relationships. “Ozempic, like other medications that result in ...
Eating disorder specialists say they're seeing an influx of patients who've relapsed after getting shots not meant for them.
COPENHAGEN, Dec 17 — Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two Danish ...
Semaglutide, the active ingredient in the popular weight loss drugs Wegovy and Ozempic, may help stop amyloid plaques and tau from developing in the brain, ...
Several recent studies have found a possible connection between semaglutide use and a rare condition that causes sudden vision loss.
A vision-threatening eye condition may be linked to Ozempic. Meanwhile, Nearly 80% of doctors are using telemedicine weekly, a new Doximity report finds.
After two independent studies suggest the use of Ozempic increases the risk of causing blindness, the Danish Medicines Agency has asked for a probe.
Microdosing is the latest A-list trend. Times fashion editor Harriet Walker talks to the private doctors who are prescribing 'bespoke' weight-loss drugs and ...